logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
L

Liqun Zou

sichuan university

24H指数
228论文数
2.1K被引数
收录论文 63
发表时间
logo
Bispecific Antibody-Based Combination Therapies for B-Cell Lymphomas: Current Evidence and Future Perspectives基于双特异性抗体的B细胞淋巴瘤联合疗法：当前证据和未来展望
errInternational Journal of Cancer
IF4.7
err2026-08-15
err0
PREAI
errMo Cheng; Wenke Li; Ming Liu; Liqun Zou
err分享
err收藏
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study阿贝西替，一种组蛋白去乙酰化酶抑制剂，用于复发或难治性滤泡性淋巴瘤患者：一项多中心、单臂Ⅱ期研究
errSignal Transduction and Targeted Therapy
IF52.7
err2026-04-01
err0
errOAAI
errGui, Lin; Liu, Haifeng; Wang, Huaqing; Cao, Junning; Li, Yufu; Yu, Yong; Gao, Yuhuan; Li, Zhenling; Shen, Jianzhen; Zhang, Lei; Zhang, Qingyuan; Pan, Hongming; Zheng, Meifang; Ke, Xiaoyan; He, Hesheng; Guo, Shuangshuang; Wang, Yihao; Xu, Xiaohong; Zou, Liqun; Wu, Wentao; Shi, Yuankai
err分享
err收藏
The impact of professional identity on nurses’ mental health status after the COVID-19 public health emergency: a cross-sectional survey后COVID-19公共卫生紧急状态下专业身份对护士心理健康状况的影响：一项横断面调查
errFrontiers in Public Health
IF3.4
err2025-11-18
err0
errOAAI
errNan Xie; Liqun Zou; Zhenfei Yuan
err分享
err收藏
Liquid biopsy in orthopedic trauma: exosomes as functional mediators and mechanistic indicators in post-traumatic complications骨科创伤中的液体活检：外泌体作为功能介导物和创伤后并发症的机制指示物
errFrontiers in Medicine
IF3
err2025-11-05
err0
errOAAI
errJinyu Gan; Shuangting Zhong; Juan Xie; Liqun Zou
err分享
err收藏
The prognostic value of hemoglobin, albumin, lymphocyte, and platelet (HALP) score in low-risk and early-stage extranodal natural killer/T cell lymphoma低风险和外周早期结外自然杀伤/T细胞淋巴瘤中血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分的预后价值
errAnnals of Hematology
IF2.4
err2025-08-01
err0
errOAAI
errNa Li; Jing Huang; Yuping Xie; You Feng; Shihui Min; Li-qun Zou
err分享
err收藏
Chinese expert consensus on hematologic malignancy karyotyping中国血液恶性肿瘤核型分析专家共识
errClinica Chimica Acta
IF2.9
err2025-07-26
err0
PREAI
errZailin Yang; Shuang Chen; Mingyu Zhao; Fei Gao; Jianwei Li; Yu Peng; Tingting Jiang; Jun Zhang; Xinyi Tang; Yakun Zhang; Fan Chen; Hongwei Chen; Pu Chen; Siyu Chen; Xingqin Huang; Yujiao Jia; Xiaohong Xie; Chengwen Li; Guoxia Li; Jieping Li; Zhaoquan Li; Zheng Li; Rong Liang; Jie Liu; Ling Liu; Fang Long; Zhigao Long; Jinglong Lü; Qiang Ma; Ping Mao; Bin Pan; Jinlan Pan; Ling Pan; Xiangui Peng; Xing Qiang; Longrong Ran; Fanggang Ren; Xiuhua Sun; Dangfeng Wang; Li Wang; Shiyi Wang; Xingzhe Wang; Yanfang Wang; Ying Wang; Zhiyuan Wang; Xia Wei; Zhiwei Wu; Menghua Wu; Xuelian Wu; Jianwen Xiao; Junjun Yang; Zesong Yang; Yuanyou Yao; Yi Ying; Yalan Yu; Meiling Zhang; Ping Zhang; Wei Zhang; Hui Zhou; Jianfeng Zhou; Mingxia Zhu; Liqun Zou; Cui Mao; Ximing Yang; Yao Liu
err分享
err收藏
Prognostic role of prognostic nutritional index in patients with lymphoma-associated hemophagocytic lymphohistiocytosis预后营养指数在淋巴瘤相关性噬血细胞性淋巴组织细胞增多症患者中的预后作用
errFUTURE ONCOLOGY
IF2.6
err2025-05-22
err0
PREAI
errLi, Na; Feng, You; Zou, Liqun
err分享
err收藏
Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trialTifcemalimab单药治疗或联合toripalimab治疗复发/难治性淋巴瘤：一项I期临床试验
errNATURE COMMUNICATIONS
IF15.7
err2025-05-16
err0
errOAAI
errSong, Yuqin; Ma, Jun; Zhang, Huilai; Xie, Yan; Peng, Zhigang; Shuang, Yuerong; Li, Fei; Li, Yufu; Yang, Haiyan; Zou, Liqun; Zhao, Weili; Huang, Wenrong; Huang, Yunhong; Zhou, Hui; Wang, Yifan; Wang, Weiwei; Xu, Jing; Deng, Rong; Meng, Qin
err分享
err收藏
Retrospective study of chidamide-containing regimens as maintenance therapy among T- and NK-cell lymphoma patients
errFRONTIERS IN ONCOLOGY
IF3.3
err2025-03-03
err0
errOAAI
errHai, Tao; Wu, Wanchun; Ren, Kexin; Li, Na; Zou, Liqun
err分享
err收藏
Diffuse Large B-Cell Lymphoma Patients with Bone Involvement Treated with Polatuzumab Vedotin-Based Therapy Exhibit Poorer Progression-Free Survival: A Real-World Retrospective Study in Chinese Patients弥漫性大B细胞淋巴瘤伴骨侵犯患者接受Polatuzumab Vedotin为基础的治疗后无进展生存期较差：一项中国患者的真实世界回顾性研究
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errFang, Tian; Ren, Kexing; Zou, Liqun
err分享
err收藏
Efficacy and Tolerability of Dose-Adjusted Brentuximab Vedotin in Lymphoma: A Chinese Single-Center Retrospective Chart Review Study剂量调整的 Brentuximab Vedotin 在淋巴瘤中的有效性与耐受性：一项中国单中心回顾性病历审查研究
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errFang, Tian; Ren, Kexing; Zou, Liqun
err分享
err收藏
Reduction of Radiotherapy Intensity after Achieving Complete Remission with Induction Chemotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma: A Prospective Study在诱导化疗达到完全缓解后，对新诊断的I/II期结外NK/T细胞淋巴瘤降低放射治疗强度的前瞻性研究
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errChen, Xi; Xie, Li; Jiang, Ming; Zou, Liqun
err分享
err收藏
Differences in axillary response and treatment implications in HER2 positive node positive breast cancer during neoadjuvant HER2 targeted dual therapy新辅助HER2靶向双重治疗期间HER2阳性淋巴结阳性乳腺癌腋窝反应和治疗意义的差异
errSCIENTIFIC REPORTS
IF3.9
err2024-11-01
err1
errOAAI
errMou, Exian; Ji, Juan; Liu, Shiwei; Shu, Lan; Zou, Liqun; Li, Zhuoxuan
err分享
err收藏
Real-world efficacy of chidamide plus R-CHOP in newly diagnosed double-expressor diffuse large B-cell lymphoma
errTHERAPEUTIC ADVANCES IN HEMATOLOGY
IF3.1
err2024-10-28
err2
errOAAI
errChen, Xi; Xie, Li; Zhu, JunMin; Liang, Lijie; Zou, Bingwen; Zou, Liqun
err分享
err收藏
Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial
errHAEMATOLOGICA
IF7.9
err2024-09-05
err1
errOAAI
errLin, Ningjing; Sun, Xiuhua; Zhou, Hui; Zou, Liqun; Zhou, Keshu; Liu, Lihong; Yang, Haiyan; Hu, Kai; Cai, Qingqing; Liu, Yao; Jin, Jie; Zhang, Liling; Li, Wenyu; Guo, Ye; Yang, Wei; Luo, Feng; Wang, Zhenguang; Zhu, Rong; Yang, Lei; Song, Dan; Song, Yuqin; Zhu, Jun
err分享
err收藏
Insights into uveitis from Brentuximab vedotin in refractory Hodgkin's lymphoma: a case report and brief reviewBrentuximab vedotin对难治性霍奇金淋巴瘤的葡萄膜炎的见解: 一例病例报告和简要回顾
errFRONTIERS IN ONCOLOGY
IF3.3
err2024-08-05
err0
errOAAI
errLiu, Mengyuan; Ren, Kexing; Ai, Ping; Zou, Liqun
err分享
err收藏
Treatment advances in high-grade gliomas
errFRONTIERS IN ONCOLOGY
IF3.3
err2024-04-10
err5
errOAAI
errChen, Xi; Cui, Yi; Zou, Liqun
err分享
err收藏
Potential Mechanism of Tibetan Medicine Liuwei Muxiang Pills against Colorectal Cancer: Network Pharmacology and Bioinformatics Analyses
errPHARMACEUTICALS
IF4.8
err2024-03-27
err1
errOAAI
errQi, Shaochong; Liang, Xinyu; Wang, Zijing; Jin, Haoran; Zou, Liqun; Yang, Jinlin
err分享
err收藏
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma
errLEUKEMIA
IF13.4
err2024-02-20
err0
PREAI
errChen, Zegeng; Huang, He; Huang, Huageng; Yu, Le; Weng, Huawei; Xiao, Jian; Zou, Liqun; Zhang, Huilai; Liang, Chaoyong; Zhou, Hui; Guo, Hongqiang; Wang, Zhao; Li, Zhiming; Wu, Tao; Zhang, Hongyu; Wu, Huijing; Peng, Zhigang; Zhai, Linzhu; Chen, Xinggui; Liang, Yang; Hong, Huangming; Lin, Tongyu
err分享
err收藏
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors
errHAEMATOLOGICA
IF7.9
err2024-01-18
err2
errOAAI
errSong, Yuqin; Cao, Junning; Zhang, Qingyuan; Li, Caixia; Qiu, Lugui; Qi, Junyuan; Zhang, Huilai; Li, Wenyu; Liu, Lihong; Jing, Hongmei; Zhou, Keshu; Zhang, Weijing; Zhang, Liling; Li, Daqi; Zou, Liqun; Yang, Haiyan; Qian, Wenbin; Zhou, Hui; Hu, Jianda; Yin, Hongyan; Fu, Sisi; Fan, Songhua; Xu, Qian; Wang, Jian; Jia, Xiaoyun; Dai, Guangxiu; Su, Weiguo; Zhu, Jun
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
张
张丽 (Li Zhang)
H 指数: 112 · 论文数: 4.1K
Y
Yuquan Wei
H 指数: 111 · 论文数: 1.2K
王建 封面图
王建 (Jian Wang)
H 指数: 100 · 论文数: 1.3K
Xiaoling Li 封面图
Xiaoling Li (Xiaoling Li)
H 指数: 91 · 论文数: 606
赵
赵旭东 (Xudong Zhao)
H 指数: 86 · 论文数: 737
查看更多